Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Find out Which Dividend Growth ETF Has Low Fees and what to look for in expense ratios. Get tips to compare funds effectively.
28,299 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
New market dynamics push five names into focus as AI, memory demand, and energy trends redefine winners and losers. A...
A rising number of high-income households are using a backdoor Roth move high to access $7,500 of tax-free retirement...
Remitly is more than a remittance app. This article dives into why remitly could hidden compounder in cross-border pa...
Markets await Kevin Warsh’s first Fed policy decision amid oil price movements and a fragile housing sector. This rep...
Voters in California face a pivotal choice on a billionaire wealth tax and new limits on local transfer taxes as hous...
Chipotle launches its first Monterrey location with Alsea, kicking off a broader push into Mexico. The move tests wal...
December data show the fed's favored inflation gauge remaining hotter than expected, underscoring persistent price pr...
Analysts warn that Nvidia's GTC event may not deliver the dramatic stock move some investors were banking on. The con...
A New Mexico jury found Meta's platforms harmful to children's mental health, ordering a $375 million penalty and sig...
A timely look at how george kamel’s message couples shapes decisions on budgeting and investing as households navigat...
When a fund sells a big stake in Champion Homes, it can reveal more about market sentiment than a quarterly report. T...